Stable formulations of anti-TIGIT antibodies alone and in combination with programmed death receptor 1 (PD-1) antibodies, and their methods of use

MA50661AUndetermined Publication Date: 2020-08-05MERCK SHARP & DOHME CORP

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA50661
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2017-05-02
Filing Date: 2018-05-01
Publication Date: 2020-08-05

Application Information

Patent Timeline

02 May 2017

Priority

01 May 2018

Application

MA50661

05 Aug 2020

Publication

MA50661A

IPC: A61K39/00; A61K39/395; A61P31/12; A61P35/00

CPC: A61P35/00; A61P31/12; A61K39/39591; C07K16/2803; C07K16/2818; A61K2039/507; C07K2317/94; A61K9/0019

Inventors: DE Arnab; NARASIMHAN Chakravarthy Nachu

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.